Full Text View
Tabular View
No Study Results Posted
Related Studies
Ischemic Optic Neuropathy Decompression Trial Followup (IONDT Followup)
This study is ongoing, but not recruiting participants.
First Received: September 23, 1999   Last Updated: May 25, 2006   History of Changes
Sponsor: National Eye Institute (NEI)
Information provided by: National Eye Institute (NEI)
ClinicalTrials.gov Identifier: NCT00000126
  Purpose

To follow all patients enrolled in the original Ischemic Optic Neuropathy Decompression Trial (IONDT) to determine (1) the incidence of non-arteritic ischemic optic neuropathy (NAION) in the second eye, (2) changes in visual acuity over time in both the study and second eye, and (3) other aspects of the natural history of NAION.


Condition Intervention
Ischemic Optic Neuropathy
Procedure: Surgery

Study Type: Observational
Study Design: Longitudinal

Resource links provided by NLM:


Further study details as provided by National Eye Institute (NEI):

Study Start Date: October 1994
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   50 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

All living patients from the 420 patients originally enrolled in the IONDT have been asked to participate in the IONDT Followup Study. No new patients are being recruited.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00000126

  Hide Study Locations
Locations
United States, California
Doheny Eye Institute, University of Southern California
Los Angeles, California, United States
Jules Stein Eye Institute
Los Angeles, California, United States
Department of Ophthalmology, University of California, San Francisco
San Francisco, California, United States
United States, Florida
Department of Ophthalmology, University of Florida
Gainesville, Florida, United States
United States, Georgia
Emory Eye Center, Emory University
Atlanta, Georgia, United States
United States, Illinois
Department of Ophthalmology, University of Illinois
Chicago, Illinois, United States
United States, Kentucky
Department of Ophthalmology, University of Kentucky
Lexington, Kentucky, United States
United States, Maryland
University of Maryland
Baltimore, Maryland, United States
United States, Michigan
W.K. Kellogg Eye Center, University of Michigan
Ann Arbor, Michigan, United States
Department of Ophthalmology, Michigan State University
East Lansing, Michigan, United States
William Beaumont Eye Institute, William Beaumont Hospital
Royal Oak, Michigan, United States
United States, Minnesota
Mayo Clinic
Rochester, Minnesota, United States
United States, Missouri
Mason Institute of Ophthalmology, University of Missouri - Columbia
Columbia, Missouri, United States
St. Louis University, Anheuser-Busch Eye Institute
St. Louis, Missouri, United States
United States, New York
SUNY Health Science Center, Department of Neurology
Syracuse, New York, United States
United States, North Carolina
Carolinas Medical Center
Charlotte, North Carolina, United States
United States, Ohio
The Cleveland Clinic Foundation
Cleveland, Ohio, United States
United States, Pennsylvania
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
United States, South Carolina
University of South Carolina, Department of Ophthalmology
Columbia, South Carolina, United States
United States, Texas
University of Texas
Houston, Texas, United States
United States, Utah
University of Utah, Department of Ophthalmology
Salt Lake City, Utah, United States
United States, Virginia
University of Virginia, Department of Ophthalmology
Charlottesville, Virginia, United States
Medical College of Virginia, Department of Neurology
Richmond, Virginia, United States
United States, West Virginia
West Virginia University, Department of Neurology
Morgantown, West Virginia, United States
Sponsors and Collaborators
  More Information

Additional Information:
No publications provided

Study ID Numbers: NEI-25
Study First Received: September 23, 1999
Last Updated: May 25, 2006
ClinicalTrials.gov Identifier: NCT00000126     History of Changes
Health Authority: United States: Federal Government

Keywords provided by National Eye Institute (NEI):
Non-arteritic Ischemic Optic Neuropathy

Additional relevant MeSH terms:
Pathologic Processes
Eye Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Optic Nerve Diseases
Cranial Nerve Diseases
Ischemia
Optic Neuropathy, Ischemic

ClinicalTrials.gov processed this record on November 25, 2009